A day after resigning his seat in the U.S. House, former Rep. Chris Collins (R-N.Y.) pleaded guilty Tuesday to one count of conspiracy to commit securities fraud and one count of lying to the FBI when interviewed about insider trading involving Australian biotech Innate Immunotherapeutics Ltd.